CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: share-based compensation expense

What this measure means

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2007-12-30 to 2025-12-27. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: total assets
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: total liabilities
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: stockholders equity
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: cash and cash equivalents
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: net income or loss
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: operating cash flow
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: revenue
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: contract revenue excluding tax
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: financing cash flow
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: investing cash flow
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: retained earnings or deficit
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: basic weighted-average shares
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: diluted weighted-average shares
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: basic earnings per share
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: diluted earnings per share
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: income tax expense or benefit
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: net property, plant and equipment
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: operating income or loss
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: current assets
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: interest expense
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: current liabilities
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: current accounts payable
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: goodwill carrying amount
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: net finite-lived intangible assets
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: net current accounts receivable
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: common-stock repurchase payments
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: net inventory
• CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: selling, general and administrative expense

Inspect the source

Entity

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. / CIK 0001100682

Captured

2026-09-20T05:23:01.109Z

SEC response SHA-256

22884da0d898a58bf99c4f5d4c2de6e1fe324d32bdaa4d1b1ffb0a2a61e1a4cd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001100682.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))